Skip to main content
HomeConference final 2021


Saturday, February 11, 2023... Details will be provided soon.


Impact of COVID-19 on Clinical Exercise Physiology: Performance, Practice, & Patients 

This event was held 02 October 2021. Registration was FREE to student CEPA members and just $25 to professional and associate CEPA members. A recording of the event was provide to all who register. The event was approved for 5 (five) CECs by the ACSM.

10:00 am to 10:15 am EDT
Opening Remarks
CEPA President: Laura Richardson, PhD, RCEP, FACSM; Summa Health System
Program Chair: Samuel Headley, PhD, RCEP, FACSM; Springfield College

Opening Remarks sponsored by: 

10:15 am to 11:10 am EDT
COVID-19 and Cardiovascular Health- Implications for Patients and Exercise
Mark Ross, BSc Hons, MSc, PGCE, PhD; Edinburgh Napier University

Dr. Ross is the Program Leader for the BSc Honors Sport and Exercise Science degree program at Edinburgh Napier University. His research interests lie in vascular health, age and exercise, with specific focus on circulating cells in the blood which stimulate vascular regeneration and repair, working towards quantifying the bone marrow-derived stem cell response to acute and chronic exercise in both young and older adults. Recently Mark has been involved in investigating how exercise may counteract the negative side-effects of chemotherapy on blood vessels of breast cancer patients, as well as the impact of COVID-19 on vascular health.

11:15 am to 12:10 am EDT
Home-Based Cardiac and Pulmonary Rehabilitation- Veterans Affairs Experience
Kariann Drwal, MS, CCRP, RCEP, ATC/LAT; Iowa City Veterans Affairs Healthcare System

Ms Drwal is the National Program Director of the Office of Rural Health Home-based Cardiac and Pulmonary Rehabilitation Programs in the Iowa City Veterans Affairs Healthcare System. She received her bachelor’s degree from Buena Vista University and her Master of Science degree from Eastern Illinois University. Kariann joined the Iowa City VA in 2010, and since then has supported the development of the home-based cardiac and pulmonary rehabilitation program, as well as providing oversight to the dissemination of the program to other VA facilities across the country.

12:15 pm to 1:10 pm EDT
Exercise is Medicine for Immune Function: Implication for COVID-19
David C. Nieman, DrPH, FACSM; Appalachian State University

Dr. Nieman is a professor in the Department of Biology, College of Arts and Sciences, at Appalachian State University, and director of the Human Performance Lab at the North Carolina Research Campus (NCRC) in Kannapolis, NC. He is a pioneer in the research area of exercise and nutrition immunology, and helped establish that 1) regular moderate exercise lowers upper respiratory tract infection rates while improving immunosurveillance, 2) heavy exertion increases infection rates while causing transient changes in immune function, and 3) that carbohydrate and flavonoid ingestion by athletes attenuates exercise-induced inflammation. Dr. Nieman’s current work is centered on investigating unique nutritional products as countermeasures to exercise- and obesity-induced immune dysfunction, inflammation, illness, and oxidative stress using a multi-omics approach.

1:10 pm to 1:40 pm EDT- Break

1:40 pm to 2:35 pm EDT
Exercise Considerations and Prescription for the COVID Long-Hauler

Cemal Ozemek, PhD, ACSM-CEP, FACSM

This presentation sponsored by:

Dr. Ozemak is a Clinical Associate Professor, Director of the Cardiac Rehabilitation Program and Director of the Professional Doctor of Clinical Exercise Physiology Program at the University of Illinois at Chicago. He received his PhD from Ball State University and completed a postdoctoral research fellowship at the University of Colorado Anschutz Medical Campus. Dr. Ozemek’s research interests include cardiac, vascular and cardiorespiratory adaptations to physical activity interventions in patients with chronic health conditions and investigating the efficacy of community-based health and wellness promotion strategies. He has over 10 years of experience working in clinical settings that provide exercise testing/prescription and monitoring services for outpatient cardiac, pulmonary, bariatric surgery and cancer patients as well as healthy older adults. 

2:40 pm to 3:10 pm EDT
Impact of COVID-19 Pandemic on the Physical Activity Level of Patients with Cystic Fibrosis: Moving Forward From Here
Joseph Russo MD, MS; University of Florida Shands Medical Center

Dr. Russo completed medical residency in the Internal Medicine-Pediatrics program at the University of Tennessee Health Science Center in Memphis, TN, and is currently pursuing pulmonology fellowship at the University of Florida Shands Medical Center in Gainesville, FL. Prior to medical school he earned his master’s degree in exercise science from Bloomsburg University in Pennsylvania and worked for several years as a clinical exercise physiologist and clinical operations specialist for a mobile cardiopulmonary exercise testing company serving primary care offices. He has recently developed an annual cardiopulmonary exercise testing program for both pediatric and adult patients with cystic fibrosis at the UF Cystic Fibrosis Center.

3:15 pm to 4:10 pm EDT
Pulmonary Consequences of COVID-19: Impacts on Exercise Responses and Implications for Clinical Practice
Hayley Lewthwaite, PhD, AEP; University of Newcastle

Dr. Lewthwaite a lecturer in Clinical Exercise Physiology at University of Newcastle, Australia and an Accredited Exercise Physiologist and Exercise Scientist with Exercise and Sports Science Australia. Hayley received a PhD in exercise physiology in 2018 from the University of South Australia, after which, she completed a postdoctoral research fellowship in respiratory physiology at McGill University, Montréal, Canada. Hayley’s research focuses on exploring pathophysiological mechanisms underpinning activity-related symptoms (such as breathlessness) in people with chronic lung disease, with the aim of optimizing symptom-specific assessment and management approaches. For the management of chronic lung disease symptoms, Hayley explores both pharmacological and non-pharmacological options to be used as stand-alone therapies in day-to-day life or as adjunct therapies to supervised exercise training.

4:10 pm to 5:00 pm EDT
Discussion & Closing Remarks

Samuel Headley, PhD, RCEP, FACSM; Springfield College